BJ
LFCR icon

BlackRock Japan’s Lifecore Biomedical LFCR Stock Holding History

BlackRock Japan’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,137
Closed -$14K – 1351
2014
Q3 		$14K Sell
1,137
-723
-39% -$9.03K ﹤0.01% 1189
2014
Q2 		$23K Hold
1,860
– – ﹤0.01% 1140
2014
Q1 		$21K Buy
1,860
+487
+35% +$5.34K ﹤0.01% 1269
2013
Q4 		$17K Sell
1,373
-2,268
-62% -$27.1K ﹤0.01% 1249
2013
Q3 		$44K Buy
3,641
+1,764
+94% +$24.6K ﹤0.01% 1144
2013
Q2 		$25K Buy
+1,877
New +$26K ﹤0.01% 1194

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock Japan's LFCR Position: Q4 2014 in Review

BlackRock Japan sold out of Lifecore Biomedical (LFCR) in Q4 2014, closing a stake of 1,137 shares — an estimated $14K sold.

BlackRock Japan first reported a position in LFCR in Q2 2013 and held it in 6 quarters. The position peaked at $44K in Q3 2013. 109 funds tracked by Wall St. Rank hold LFCR as of Q4 2014.

  • BlackRock Japan reported no remaining Lifecore Biomedical position as of Q4 2014 after selling out during the quarter.
  • BlackRock Japan sold 1,137 Lifecore Biomedical shares in Q4 2014, an estimated $14K.
  • BlackRock Japan first reported a position in Lifecore Biomedical in Q2 2013 and held it in 6 quarters.
  • BlackRock Japan's Lifecore Biomedical position peaked at $44K in Q3 2013.
  • 109 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2014.

Based on BlackRock Japan's 13F filing for Q4 2014, filed 9 Feb 2015.